Dicyclomine recalls

The FDA has published 4 recalls involving Dicyclomine since 2014. The latest was reported on 12 Aug 2026. Most were for labeling errors. Aurobindo Pharma USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2014
Last 12 months1reported
Class I00% of total
Ongoing2latest 12 Aug 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 4 100%Class III 0 0%

By year

Ongoing dicyclomine recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDicyclomine Hydrochloride Capsules, USP, 10mg recalledDicyclomine HydrochlorideAurobindo Pharma USAPackaging DefectsNationwide
DrugCLASS IIDicyclomine Hydrochloride Injection USP, 20 mg/ (10 mg/mL) ampules recalledAkornPotency & AssayNationwide

All dicyclomine recalls, newest first

4 total

Should you stop taking Dicyclomine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.